Effect of race and histology on patterns of failure in women with early stage endometrial cancer treated with high dose rate brachytherapy.

作者: Alaattin Ozen , Aaron D. Falchook , Mahesh A. Varia , Paola Gehrig , Ellen L. Jones

DOI: 10.1016/J.YGYNO.2015.05.025

关键词:

摘要: Abstract Background Clinical trials have helped refine management of early stage endometrial cancer (EC). For patients with intermediate risk features, adjuvant radiation is considered, primarily vaginal cuff brachytherapy. higher patients, there may be a role for chemotherapy and radiation. The purpose this study to examine patterns failure EC treated postoperative high dose rate Methods In single institution retrospective cohort study, 208 women who received definitive therapy between January 1, 2000 2013 were identified. Results Median follow-up was 46.4 (range, 6.2–137.3) months. Thirteen (6.3%) developed locoregional recurrent disease 15 (7.2%) distant metastasis. Freedom from recurrence at 5years 88.6% white 60.5% black (p=0.0093). Five year free survival (RFS) vs. 82.9% 48.9% (p=0.0007). overall (OS) 86.8% 59.5% (p=0.0023). Black unfavorable histology brachytherapy had 15% rate, more than double the local compared AA endometrioid any (6% rate). Conclusions experience increased rates worse patients. Patterns in group also indicate (type II).

参考文章(29)
M Onsrud, J Aalders, P Kolstad, V Abeler, Postoperative External Irradiation and Prognostic Parameters in Stage I Endometrial Carcinoma: Clinical and Histopathologic Study of 540 Patients Obstetrics & Gynecology. ,vol. 56, pp. 419- 427 ,(1980)
G. Larry Maxwell, Chunqiao Tian, John I. Risinger, Chad A. Hamilton, Richard R. Barakat, , Racial disparities in recurrence among patients with early-stage endometrial cancer Cancer. ,vol. 113, pp. 1431- 1437 ,(2008) , 10.1002/CNCR.23717
Andrew Berchuck, John I. Risinger, G. Larry Maxwell, Angeles A. Alvarez, J. Carl Barrett, Richard K. Dodge, Kate A. Hayes, Racial Disparity in the Frequency of PTEN Mutations, but not Microsatellite Instability, in Advanced Endometrial Cancers Clinical Cancer Research. ,vol. 6, pp. 2999- 3005 ,(2000)
W.T. Creasman, F. Odicino, P. Maisonneuve, U. Beller, J.L. Benedet, A.P.M. Heintz, H.Y.S. Ngan, S. Pecorelli, Carcinoma of the Corpus Uteri International Journal of Gynecology & Obstetrics. ,vol. 83, pp. 79- 118 ,(2003) , 10.1016/S0020-7292(03)90116-0
H. Lukka, T. Whelan, P. Blake, A.M. Swart, J. Orton, A. Branson, M. Parmar, C. Murray, W. Qian, Adjuvant External Beam Radiotherapy in the Treatment of Endometrial Cancer: Results of the Randomized MRC ASTEC and NCIC CTG EN.5 Trials, A Systematic Review and Meta-analysis International Journal of Radiation Oncology Biology Physics. ,vol. 72, ,(2008) , 10.1016/J.IJROBP.2008.06.1176
Matthew F. Kohler, Pamela Carney, Richard Dodge, John T. Soper, Daniel L. Clarke-Pearson, Jeffrey R. Marks, Andrew Berchuck, p53 overexpression in advanced-stage endometrial adenocarcinoma American Journal of Obstetrics and Gynecology. ,vol. 175, pp. 1246- 1252 ,(1996) , 10.1016/S0002-9378(96)70036-4
Jack B. Basil, Paul J. Goodfellow, Janet S. Rader, David G. Mutch, Thomas J. Herzog, Clinical significance of microsatellite instability in endometrial carcinoma. Cancer. ,vol. 89, pp. 1758- 1764 ,(2000) , 10.1002/1097-0142(20001015)89:8<1758::AID-CNCR16>3.0.CO;2-A